MyFildena.com is an online pharmacy founded in 2010 with the aim of offering pharmacy products, delivering them to our clients’ homes. Achieving a broad catalog at a competitive price and providing a comfortable, fast and quality service is the maximum we aspire to.
In 2015, we were one of the first pharmacies to obtain the seal of the Ministry of Health for the sale of OTC medicines, that is, over-the-counter medications that do not require a medical prescription. In 2017, we received the CECARM award for the Best Online Store.
In recent years we have managed to establish ourselves as one of the reference pharmacies in the online sector, managing to offer our clients more than 24,000 referrals with a service of the highest quality. That is why more than 300,000 customers have already relied on MyFildena for their pharmacy purchases.
Authoritative hierarchy of medical review experts takes control of accuracy of the content from highly respected, original and credible scientific sources. All materials are relevant and approved by medical experts for usage by the public. We collaborate with external medical experts and scientific researchers to advance clinical research and enhance public health.
Constant inspection of published articles is applied monthly according to government regulations by U.S. Food and Drug Administration, World Health Organization, National Institutes of Health and Centers for Disease Control and Prevention.
List of medical review experts:
Jose Roberto Trujillo is president and director of TruCytonics LLC, a biotechnology company based in Maryland. He is founder and president of the Pan American Society of Neurovirology and President of the Medical Science Foundation on Behalf of the Americas. Trujillo is a pioneer in the field of neurovirology. He was the first doctoral student at Harvard University to combine studies in neuroscience and virology. “Dr. Trujillo was the first neurovirologist at Harvard. He remained there as a neurovirology and retrovirus researcher until 2002.”
Carles Cordon is a American doctor and oncologist. Honorary doctorate from the University of Barcelona, he stands out for his research on the molecular mechanisms that trigger cancer. Cordón graduated in Medicine from the University of Barcelona in 1980. Doctor in Cellular and Genetic Biology from Cornell University in 1985, a year later he began working at the Memorial Sloan Kettering Cancer Center in New York, where he has developed his research career. Since 1995 he is director of the Molecular Pathology Division of the center and professor at Columbia University. He has excelled in his work on Molecular Oncological Pathology He is an Honorary Doctorate from the University of Barcelona (2006) and an honorary academic from the Royal Academy of Medicine of Catalonia (2007). April 2007 was recognized with the Gold Medal of the city of Calella.
Leroy Hood (b. October 10, 1938) is an American biologist. In 2003, he won the Lemelson-MIT Award for having invented “four instruments that deciphered much of the mystery of human biology” helping to decode the genome. 1 Hood also won the 2002 Kyoto Award for Advanced Technology, and the Albert Award Lasker by Basic Medical Research in 1987. His inventions include automated DNA sequencing and a tool, also automated, to synthesize it. He is the co-founder of the Institute for Systems Biology. He is recognized as one of the world’s leading scientists in the field of molecular biotechnology and genomics. He has several patents and awards for his scientific discoveries and has dedicated his life to making science accessible and understandable to the general public, especially children.
Edzard Ernst, born on January 30, 1948 in Wiesbaden (Germany), is a professor of medicine and researcher specialized in the study of alternative medicine. He was appointed professor of complementary medicine at the University of Exeter, the first academic position of this type in the world. Ernst was born and trained in Germany, where he began his medical career at a homeopathic hospital in Munich, and has been a British citizen since 1999. He served as president of Physical Medicine and rehabilitation at the University of Vienna, however, he left office in 1993 to establish the department of Complementary Medicine at the University of Exeter in England. In 2002, he became director of complementary medicine at the Peninsula College of Medicine and Dentistry. Ernst was the first occupant of the Laing Chair in Complementary Medicine, from which he retired in 2011.
Ignacio Melero Bermejo is a Spanish researcher, specialist in immunotherapy. Professor of Immunology of the University of Navarra, principal investigator of CIMA2 and corresponding academic of the Royal National Academy of Medicine. After graduating in Medicine from the University of Navarra, he completed the specialty in Immunology at the University Hospital of the Princess (Madrid). At the end of the specialty, he traveled to Seattle (United States), where he worked at the pharmaceutical research institute of the company Bristol-Myers Squibb together with doctors Lieping Chen and Karl E. Hellstrom, between 1994 and 1998. There he obtained the identification of 4-1BB (CD137) as a target in cancer immunotherapy. In 1998 he returned to Pamplona, joining CIMA and the Clínica Universidad de Navarra where he directs a translational research team that works on cancer immunotherapy strategies based on cell therapy, gene therapy and monoclonal antibodies.
David Henry Gorski is an American oncologist surgeon, a professor of surgery at the Wayne State University School of Medicine and a surgical oncologist at the Barbara Ann Karmanos Cancer Institute, specializing in breast cancer surgery.He is vocally skeptical and critical of Alternative medicine and anti-vaccination movement. He is the author of the blog, Respectful Insolence, and editor-in-chief of the Science-Based Medicine website. Gorski attended the University of Michigan, where he received an MD in 1988. In 1989, he entered a residence in general surgery at the University Hospitals of Cleveland. Gorski left his residence to do a doctorate in cellular physiology at the Case University of the Western Reserve, which he completed in 1994, with a dissertation entitled “Expression and regulation in vascular myocytes of the Homeobox gene.” After this Gorski continued his residency (1993-96) and completed a research grant in surgical oncology (1996-99) at the University of Chicago.
Luigi Cubbedu (Rome, Italy, December 12, 1942) is Associate Professor and researcher assigned to the Pharmacology Chair of the Faculty of Pharmacy of the Central University of Venezuela and to the Department of Pharmaceutical Sciences of NOVA-Southeastern University (NSU) , College of Pharmacy, Health Profession Division, located in Fort Lauderdale, Florida, USA His line of study and research is related to clinical pharmacology and hypertension. He has written more than 472 articles throughout his professional career, consisting of book chapters, presentations at scientific events and revised publications.
Anita Goel is an American physicist and doctor. She is recognized for her pioneering research in nano-biophysics, particularly for the study of molecular mechanics after reading and writing information in DNA. Anita Goel received a PhD in Physics from Harvard University, where she was supervised by Nobel Prize Dudley R. Herschbach. Researcher in the Department of Physics at Harvard University. His thesis was titled Single Molecule Dynamics of Motor Enzymes Along DNA. He graduated in physics with honors and distinction from Stanford University, where he served as mentor to Nobel Laureate Steven Chu. He also graduated in Medicine from Harvard – MIT Joint Division of Health Sciences and Technology (HST). He studies living systems from physics, in particular he investigates the molecular mechanics that is behind the reading and writing of DNA information. She is the founder of Nanobiosym, a company that seeks scientific advances integrating physics, biomedicine and nanotechnology.
Address: 187 Centre St, New York, NY 10013, United States
Phone: +1 212-226-0988 +1 212-226-0989
Please use our contact form if you have any complaints about the service you have received.